|Articles|November 21, 2016
TKL Research Agrees to Sell Clinical Trials Division
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division to QuintilesIMS.
Advertisement
TKL Research, a dermatology specialty clinical research organization, has agreed to sell its Clinical Trials Division (CTD) to QuintilesIMS. TKL Research will retain its Research Clinics Division and its CTD will become part of Novella Clinical, a subsidiary of QuintilesIMS.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
2
ACT Brief: Rethinking Representation in Cancer Trials, Positive Phase IIb SLE Data, and a Major Obesity Drug Partnership
3
Fresh Starts, Real Readiness: Turning Site Initiation into a Trial Success Multiplier
4
BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal
5